Vector Biomed specializes in the design and GMP manufacturing of optimized Lentiviral vectors for clinical development, enabling rapid translation from therapeutic concepts to pre-clinical and clinical applications. The company addresses the need for high-quality, scalable vector production that meets specific requirements for gene expression and transduction efficiency.
Funding
$15M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
VGFounders
Product
Problem
Development of gene therapies is often hindered by the complexities and costs associated with producing high-quality lentiviral vectors at scale. Traditional contract development and manufacturing organizations (CDMOs) may lack the specialized expertise or efficient processes needed to rapidly advance therapeutic concepts to clinical trials.
Solution
Vector BioMed accelerates the development of gene therapies by providing optimized lentiviral vector design and GMP manufacturing services. The company employs algorithm-based vector design to enhance titer, transduction efficiency, and transgene expression, tailoring vectors to specific therapeutic needs. Vector BioMed offers rapid production of research-grade vectors for early testing and selection, followed by scalable GMP manufacturing for preclinical and clinical applications. By streamlining the vector development and manufacturing process, Vector BioMed enables partners to move quickly from concept to clinic.
Target Audience
Vector BioMed serves pharmaceutical and biotechnology companies, as well as academic organizations, involved in the development of gene therapies and requiring lentiviral vector design and manufacturing services.
Features
- Algorithm-driven lentiviral vector design for optimized performance
- Rapid production of research-grade lentiviral vectors
- Scalable GMP lentiviral vector manufacturing platform
- Support services for clinical development and commercialization
- Vector customization based on target cell, dose, and gene expression level